BRIEF published on 12/10/2024 at 16:40, 1 year 3 months ago Euromedis Laboratories: Adjustment of the liquidity contract Liquidity Securities AMF Regulation Euromedis
BRIEF published on 12/10/2024 at 16:40, 1 year 3 months ago Laboratoires Euromedis : Ajustement du contrat de liquidité Liquidité AMF Regulation Titres Euromedis
REGULATED PRESS RELEASE published on 12/10/2024 at 16:35, 1 year 3 months ago LABORATOIRES EUROMEDIS - Ajustement du contrat de liquidité Modification du contrat de liquidité entre LABORATOIRES EUROMEDIS et la Société de Bourse Gilbert Dupont pour se conformer à la décision AMF n° 2018-01 du 2 juillet 2018. Retrait de 8 000 titres le 13 décembre 2024 Société De Bourse Gilbert Dupont Contrat De Liquidité AMF Laboratoires Euromedis Retrait
BRIEF published on 12/04/2024 at 18:05, 1 year 4 months ago Euromedis Laboratories: Successful OCA issuance Convertible Bonds Dilution Oversubscription Euromedis Preferential Right
BRIEF published on 12/04/2024 at 18:05, 1 year 4 months ago Laboratoires Euromedis : Réussite de l'émission d'OCA Obligations Convertibles Dilution Sursouscription Euromedis Droit Préférentiel
REGULATED PRESS RELEASE published on 12/04/2024 at 18:00, 1 year 4 months ago Laboratoires Euromedis - Succès de l'émission d'OCA avec maintien du DPS Succès de l’émission d’OCA avec maintien du DPS. Laboratoires Euromédis annonce l'émission de 624.975 OCA pour 2.999.880 euros Obligations Convertibles Émission D'actions Maintien Du DPS Laboratoires Euromedis Émission D'OCA
REGULATED PRESS RELEASE published on 11/12/2024 at 08:47, 1 year 4 months ago Laboratoires Euromedis - Lancement d'une OCA avec maintien du DPS
BRIEF published on 10/28/2024 at 18:23, 1 year 5 months ago Euromedis Group: Half-Year Results 2024 Gross Margin Half-year Results Turnover Geopolitics Euromedis
BRIEF published on 10/28/2024 at 18:23, 1 year 5 months ago Euromedis Groupe : Résultats Semestriels 2024 Chiffre D'affaires Résultats Semestriels Marge Brute Géopolitique Euromedis
BRIEF published on 10/28/2024 at 18:20, 1 year 5 months ago Analysis of the Euromedis Laboratories Half-Year Financial Report as of June 30, 2024 Reorganization Turnover Half-yearly Finances Euromedis Laboratories Transportation Costs
Published on 04/09/2026 at 16:00, 2 hours 44 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 4 hours 4 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 4 hours 44 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 5 hours 14 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 5 hours 14 minutes ago ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Published on 04/09/2026 at 18:15, 29 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:40, 3 hours 4 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 3 hours 5 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 18:35, 9 minutes ago Mise à disposition des documents préparatoires à l'Assemblée Générale Mixte du 30 avril 2026
Published on 04/09/2026 at 18:35, 9 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 17:45, 59 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 mars 2026
